CureVac vaccine struggles in trial, particularly against variants

CureVac NV (Nasdaq: CVAC), headquartered in Germany with a U.S. office in Boston, announced on Wednesday that its Covid-19 vaccine candidate was just 47% effective against "any severity" of the disease in an interim analysis, failing to meet the criteria the company had initially laid out. Read More

Read More

To be hired at SEI is like ‘joining the family’

SEI, named a 2021 Boston Business Journal Best Place to Work among small businesses, keeps its employees tied to one another with virtual events such as cooking classes and what they call “courageous conversations.” Read More

Read More

Aqueduct Technologies looking beyond office perks

One of the best perks at Aqueduct Technologies is an annual all-expenses-paid trip for top-performing employees. Last year, the coronavirus pandemic made the trip impossible. Not to worry. This year, two years worth of winners went. Read More

Read More